ConductScience.org, home

Paper16384751

Adverse effects of topical glucocorticosteroids.

Hengge UR and 3 others. J Am Acad Dermatol, 2006. Cited by 730 papers, by iCite.

Cite this record

ConductScience Library. Adverse effects of topical glucocorticosteroids. Papers, record 16384751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16384751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Adverse effects of topical glucocorticosteroids.
PubMed
Journal
J Am Acad Dermatol
PubMed
Year
2006
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
730
iCite
Relative citation ratio, by iCite
23.9
iCite
Revised in PubMed
2022-03-31
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hengge URUlrich R
2Ruzicka TThomas
3Schwartz RARobert A
4Cork MJMichael J

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Dermatologic AgentsMajor topic
GlucocorticoidsMajor topic
Skin DiseasesMajor topic
Administration, Cutaneous
Adult
Adverse Drug Reaction Reporting Systems
Child
Drug Administration Schedule
Drug Carriers
Humans

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT04194814Skin bioMARkers for Atopic Eczema Therapy EvaluationBackgroundClinicalTrials.gov
NCT06857240Topical Ruxolitinib Cream for Refractory Cutaneous DermatomyositisBackgroundClinicalTrials.gov

Download CSV of trials

Cited by323

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 730 citations.

PMIDTitleJournalYearIn PapersSource
42858406Intra-Individual Comparative Study of Methotrexate versus Triamcinolone Acetonide Delivered via Microneedling for Recalcitrant Alopecia Areata.Dermatol Pract Concept2026https://conductscience.org/library/papers/42858406PubMed
42848405Undeclared Pharmacologically Active Ingredients in Over-the-Counter Skin Products.JAMA Netw Open2026https://conductscience.org/library/papers/42848405PubMed
42776548Efficacy and Safety of Ruxolitinib Cream in Patients With Cutaneous Lichen Planus: A Randomized Clinical Trial.JAMA Dermatol2026https://conductscience.org/library/papers/42776548PubMed
42747664Glucocorticoids: an enemy or a friend for the dermatologist? recommendations for proper use and safe discontinuation.Endocrine2026https://conductscience.org/library/papers/42747664PubMed
42701669A Prospective Study of Cutaneous Adverse Effects Among Patients With Topical Corticosteroid Abuse in a Tertiary Care Center.Cureus2026https://conductscience.org/library/papers/42701669PubMed
42622789Dissolving microneedle delivery of anemoside B4: a strategy to enhance therapeutic efficacy against psoriasis.Drug Deliv Transl Res2026https://conductscience.org/library/papers/42622789PubMed
42577692Polyphyllins ameliorate imiquimod-induced psoriatic skin barrier disruption and lesions in mice by inhibiting inflammatory infiltration with accelerated recovery effects.Front Immunol2026https://conductscience.org/library/papers/42577692PubMed
42547475
A Multi-Center, Open-Label, Single-Arm, Prospective Investigator Initiated Trial to Evaluate the Efficacy and Safety of Alitretinoin in Patients With Chronic Hand Eczema in Real-World Practice (DWALG_P401) and Overview of Korean Studies.
Ann Dermatol2026https://conductscience.org/library/papers/42547475PubMed
42514144Radiofrequency Microneedling-Mediated Enhancement in Percutaneous Delivery of Topical Triamcinolone Acetonide: An In Vivo Quantitative Study.Life (Basel)2026https://conductscience.org/library/papers/42514144PubMed
42511700Translational Assessment of a Cell-Penetrating Peptide Topical Formulation for Repairing Barrier Dysfunction in Human Skin.Int J Mol Sci2026https://conductscience.org/library/papers/42511700PubMed
42338897Stimuli-Responsive Nanocarriers for Transdermal siRNA Delivery: Mechanisms, Challenges, and Therapeutic Strategies.Int J Nanomedicine2026https://conductscience.org/library/papers/42338897PubMed
42305854Hybrid Dissolving Microneedles Incorporating Hyaluronic Acid Microdepots for Pain-free and Long-acting Corticosteroid Therapy.Biomater Res2026https://conductscience.org/library/papers/42305854PubMed
42291908Pityriasis Lichenoides et Varioliformis Acuta: A Case of Iatrogenic Cushing's Syndrome Induced by Topical Corticosteroids.Cureus2026https://conductscience.org/library/papers/42291908PubMed
42278714Topical Corticosteroid-Related Concerns and Phobic Behaviors in Saudi Arabia: A Cross-Sectional Investigation.Healthcare (Basel)2026https://conductscience.org/library/papers/42278714PubMed
42131642Topical Pimecrolimus for Treatment-Refractory Tazarotene-Induced Photosensitive Facial Erosions.Cureus2026https://conductscience.org/library/papers/42131642PubMed
42113410Real-World Infectious Outcomes with Dupilumab Compared with Proton Pump Inhibitors and Topical Steroids in Eosinophilic Esophagitis: A Multi-cohort Propensity Matched Analysis.Dig Dis Sci2026https://conductscience.org/library/papers/42113410PubMed
42107964Association of Nasal and Inhalant Corticosteroids With Pediatric Perioral Dermatitis: A TriNetX Retrospective Cohort Study.Pediatr Dermatol2026https://conductscience.org/library/papers/42107964PubMed
42072482Topical Glucocorticosteroids for Proactive Therapy of Acute Radiation-Induced Skin Injury in Head and Neck Cancer: A Systematic Review and Meta-Analysis with Trial Sequential Analysis.Biomedicines2026https://conductscience.org/library/papers/42072482PubMed
42051836Comparative Efficacy and Safety of Topical Clobetasol Propionate 0.05% Ointment Versus Topical Methotrexate 1% Gel in Limited Plaque Psoriasis: A Prospective Open-Label Study.Cureus2026https://conductscience.org/library/papers/42051836PubMed
42032028Incorporating a dermal absorption route into high throughput toxicokinetic modeling.J Expo Sci Environ Epidemiol2026https://conductscience.org/library/papers/42032028PubMed

See all 323 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16384751

GET https://conductscience.org/api/papers/v1/16384751/cited_by?page=2